top of page

Focusing on mitochondrial dysfunction to treat disease with Stealth BioTherapeutics’ CEO

Reenie McCarthy describes how her company focuses on mitochondria to treat disease and discusses regulatory and clinical learnings Stealth has had along the way.



Comentários


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page